Inventiva (IVA) Share-based Compensation (2020 - 2022)

Inventiva's (IVA) quarterly Share-based Compensation came in at $1.7 million in Q4 2022, up 8585.42% quarter-over-quarter from $19299.8 in Q1 2021.

Inventiva (IVA) Share-based Compensation (2020 - 2022) Analysis & Trends

Inventiva's Share-based Compensation history runs 3 years deep, the most recent figure standing at $1.7 million for Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	6.39 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	9.26 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	1.18 Mn
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	166.40 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	257.40 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	87.30 Mn
10	Inventiva	842.48 Mn	842.48 Mn	-	-

Download Data